ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 41462004

Ferroptosis in hematological malignancies: molecular mechanisms and therapeutic potential.

Liu J and 3 others. Cell Oncol (Dordr), 2025. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Ferroptosis in hematological malignancies: molecular mechanisms and therapeutic potential. Papers, record 41462004. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41462004

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ferroptosis in hematological malignancies: molecular mechanisms and therapeutic potential.
PubMed
Journal
Cell Oncol (Dordr)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-09-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu JJiaxi
2Liu RRui
3Miao JJiyu
4He AAili

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FerroptosisMajor topic
Hematologic NeoplasmsMajor topic
Humans
Animals
Iron
Lipid Peroxidation

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References185

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139,175,546Multidimensional role of adapalene in regulating cell death in multiple myeloma.Front Pharmacol2024https://conductscience.org/library/papers/39175546PubMed
237,172,672Andrographolide induced ferroptosis in multiple myeloma cells by regulating the P38/Nrf2/HO-1 pathway.Arch Biochem Biophys2023https://conductscience.org/library/papers/37172672PubMed
325,093,175MMSET: role and therapeutic opportunities in multiple myeloma.Biomed Res Int2014https://conductscience.org/library/papers/25093175PubMed
431,595,562Recent Progress in Ferroptosis Inducers for Cancer Therapy.Adv Mater2019https://conductscience.org/library/papers/31595562PubMed
539,490,616Rituximab induces ferroptosis and RSL3 overcomes rituximab resistance in diffuse large B-cell lymphoma cells.Arch Biochem Biophys2024https://conductscience.org/library/papers/39490616PubMed
633,803,138Antioxidant Therapy in Inflammatory Bowel Diseases.Antioxidants (Basel)2021https://conductscience.org/library/papers/33803138PubMed
741,085,851Long non-coding RNA FEZF1-AS1 suppresses ferroptosis in multiple myeloma cells through KIAA1429-mediated m6A modification.Hum Cell2025https://conductscience.org/library/papers/41085851PubMed
831,574,461Insight into the mechanism of ferroptosis inhibition by ferrostatin-1.Redox Biol2020https://conductscience.org/library/papers/31574461PubMed
932,810,738Hypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis.Redox Biol2020https://conductscience.org/library/papers/32810738PubMed
1037,308,557α-KG inhibits tumor growth of diffuse large B-cell lymphoma by inducing ROS and TP53-mediated ferroptosis.Cell Death Discov2023https://conductscience.org/library/papers/37308557PubMed

1 to 10 of 185

See all 185 references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn PapersSource
42,959,341Andrographolide in hematological malignancies: potential mechanisms and translational challenges.Front Pharmacol2026https://conductscience.org/library/papers/42959341PubMed
42,662,573Bidirectional regulation between ferroptosis and tumor-associated macrophages: mechanisms, strategies, and therapeutic perspectives.Front Oncol2026https://conductscience.org/library/papers/42662573PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41462004

GET https://conductscience.org/api/papers/v1/41462004/references?page=2

API referenceFor AI assistants